The Impact of Intensive Rosuvastatin Therapy on Cerebral Hemodynamics in Patients With Atherosclerotic Intracranial Arterial Stenosis Evaluated by Computed Tomography Perfusion (CTP)
Phase of Trial: Phase IV
Latest Information Update: 04 Apr 2018
At a glance
- Drugs Rosuvastatin (Primary)
- Indications Arteriosclerosis; Vascular restenosis
- Focus Pharmacodynamics
- 10 Jun 2017 Biomarkers information updated
- 25 Apr 2017 Planned End Date changed from 1 Jan 2017 to 28 Mar 2018.
- 25 Apr 2017 Planned primary completion date changed from 1 Jun 2016 to 28 Mar 2018.